OSP:rTTHc CCV
/ EuBiologics
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
March 25, 2025
Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults
(clinicaltrials.gov)
- P1 | N=150 | Completed | Sponsor: International Vaccine Institute | Recruiting ➔ Completed
Trial completion • Cholera
December 05, 2022
Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults
(clinicaltrials.gov)
- P1 | N=150 | Recruiting | Sponsor: International Vaccine Institute | Not yet recruiting ➔ Recruiting | Trial completion date: Oct 2023 ➔ Jan 2024 | Trial primary completion date: Apr 2023 ➔ Jul 2023
Enrollment open • Trial completion date • Trial primary completion date • Cholera
September 29, 2022
Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults
(clinicaltrials.gov)
- P1 | N=150 | Not yet recruiting | Sponsor: International Vaccine Institute
New P1 trial • Cholera
1 to 3
Of
3
Go to page
1